Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News iShares S&P/TSX Composite High Div Idx ETF T.XEI

Alternate Symbol(s):  IXEDF

The investment objective of the Fund is to provide long term capital growth by replicating, to the extent possible, the performance of the S&P TSX Composite High Dividend Index the Index, net of expenses. To achieve its investment objective the Fund uses an indexing strategy. Under this strategy, the Fund seeks to replicate the performance of the Index, net of expenses, by employing, directly... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:XEI)

BlackRock(R) Announces April Cash Distributions for the iShares(R) ETFs

Marketwired April 14, 2015

BlackRock(R) Announces March Cash Distributions for the iShares(R) ETFs

Marketwired March 11, 2015

BlackRock(R) Announces February Cash Distributions for the iShares(R) ETFs

Marketwired February 10, 2015

BlackRock(R) Announces January Cash Distributions for the iShares(R) Funds

Marketwired January 15, 2015

BlackRock(R) Announces Final Annual Reinvested Capital Gains Distributions for the iShares(R) Funds

Marketwired December 24, 2014

Blackrock(R) Announces Final December Cash Distributions for the iShares(R) Funds

Marketwired December 24, 2014

BlackRock(R) Announces Estimated Annual Reinvested Capital Gains Distributions For the iShares(R) Funds

Marketwired December 18, 2014

BlackRock(R) Announces Estimated December Cash Distributions for the iShares(R) Funds

Marketwired December 18, 2014

iShares Core Series for Canadian Investors Recognized as Best ETF Initiative of 2014 by Morningstar Canada

Marketwired November 27, 2014
View More News ››

Opinion & Analysis (TSX:XEI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:XEI)

RE:XEI - a core holding

Even after a decent run in 2021 this ETF is still a good hold into 2022.
1condor - January 11, 2022

XEI - a core holding

XEI is my number one core ETF holding for Cdn dividend stocks. Just take a look at the holdings to see how it has a great strategic setup...
Shadow1973 - February 12, 2021

XEI a Top Pick today on BNN Bloomberg Market Call

Discussed at around the 39 minute mark: https://www.bnnbloomberg.ca/market-call/full-episode-market-call-for-wednesday-august-26-2020...
Shadow1973 - August 26, 2020

XEI ETF - PAID TODAY June 30th

Monthly dividend payout CAD 0.089 per share. 6.33% yield.
Shadow1973 - June 30, 2020
View more Bullboard ››

Kane Biotech Inc.

Kane Biotech Inc.

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and ...
View More »